OR WAIT 15 SECS
Agnes Shanley is senior editor of Pharmaceutical Technology.
Despite the challenges and high cost of development, vaccine innovation is at an all-time high, as new approaches aim to improve global access.
Vaccines have had a tremendous impact on human quality of life, increasing life expectancies by eradicating deadly diseases. The cost of developing and manufacturing vaccines remains extremely high, however. Given unprofitable prices, improving access to vaccines has been a major challenge. Despite these problems, innovation is reaching a new level, while new approaches to manufacturing and distribution involving non-government organizations and contract manufacturers offshore have helped improve access. This article touches on some of the innovations, and the types of business models that have made them possible, and includes an interview with the director of the Sabin Institute.
Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
When referring to this article, please cite it as A. Shanley, "Making Vaccines Accessible," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).